CCK-A antagonists: which and how.
D'Amato
M
M
Rovati
L C
LC
D001570:Benzodiazepinones / Q000009:adverse effects / Q000494:pharmacology*; D020109:Devazepide; D005704:Gallbladder / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology; D006801:Humans; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology; D011377:Proglumide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors*; D013237:Stereoisomerism
D001570:Benzodiazepinones; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin; C053737:loxiglumide; D011377:Proglumide; D020109:Devazepide